10.1007/BF00899356
The study focuses on the synthesis of multiply substituted ethanes. The key chemicals involved include trichloroethylene, sodium phenolate, and phenol. Trichloroethylene reacts with sodium phenolate to form dichlorovinyl-phenyl ether (I), which then undergoes a complex sequence of reactions with phenol to produce tetra-(p-oxyphenyl)-ethane (IV). The study also explores the hydriding of dichlorovinyl-phenyl ether (I) using catalysts like palladium on carbon, platinum oxide, and Raney nickel, resulting in the formation of phenetol (III). Additionally, the study synthesizes derivatives of tetra-(p-oxyphenyl)-ethane (IV), such as tetra-(p-methoxyphenyl)-ethane (V), tetra-(p-ethoxyphenyl)-ethane (VI), tetra-(p-acetoxyphenyl)-ethane (VII), and tetra-(3-nitro-4-oxyphenyl)-ethane (VIII), through methylation, acetylation, and nitration processes. The study investigates the structure and properties of these compounds, including their potential estrogenic activity, which was tested but found to be inactive up to 100 gamma.
10.1016/S0960-894X(01)00782-X
The study focuses on the synthesis and biological activity of new 5-fluorocytosine derivatives, specifically 50-deoxy-N-alkyloxycarbonyl-5-fluorocytosine-50-carboxylic acid 6, which were designed to possess potent antitumor activity and low toxicity. The chemicals used in the study include 5-fluorocytosine, 1,1,1,3,3,3-hexamethyldisilazane, ammonium sulfate, b-dribofuranose 1,2,3,5-tetraacetate, N,N-diisopropylethylamine, alkyl chloroformate, sodium methoxide, and platinum oxide. These chemicals served various purposes in the synthetic route to produce the new derivatives, such as coupling agents, catalysts, and reagents for alkyloxycarbonylation, hydrolysis, and oxidation steps. The purpose of these chemicals was to create new compounds that could potentially replace or improve upon existing chemotherapeutic agents like 5-fluorouracil (5-FU) and capecitabine, offering more effective cancer treatment with fewer side effects.